Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis (Q45422773)

14 December 2017

0 references

Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis (English)

1 reference

14 December 2017

0 references

1 reference

1 reference

1

Sharon J Hutchinson

1 reference

14 December 2017

2

Sheila M Bird

1 reference

14 December 2017

David J Goldberg

3

1 reference

PubMed ID

16271348

14 December 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Clinical Gastroenterology and Hepatology

14 December 2017

1 reference

14 December 2017

3

1 reference

14 December 2017

1150-1159

1 reference

14 December 2017

11

1 reference

Estimating progression to cirrhosis in chronic hepatitis C virus infection.

14 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Is severe liver disease a common outcome for people with chronic hepatitis C?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Clinical course of hepatitis C virus during the first decade of infection: cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Risks of a range of alcohol intake on hepatitis C-related fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Alcohol use and abuse: heavy drinking among methadone clients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Patterns of drinking and drinking outcomes among drug misusers. 1-year follow-up results

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Hepatitis C and alcohol

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Hepatitis C and alcohol: interactions, outcomes, and implications

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Liver disease in alcohol and hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: Comparison with supplementary hepatitis C antibody assays

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

A classification of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

The nomenclature of chronic active hepatitis: an obituary.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Chronic hepatitis. An update on terminology and reporting.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Severity and correlates of liver disease in hepatitis C virus-infected injection drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Impact of moderate alcohol consumption on histological activity and fibrosis in patients with chronic hepatitis C, and specific influence of steatosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Progression of fibrosis in untreated patients with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Role of alcohol in the progression of liver disease caused by hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Progression of fibrosis in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Which patients with hepatitis C develop liver complications?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. The Study Group for the Prevalence and the Epidemiology of Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

The natural history of hepatitis C virus infection: host, viral, and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C?

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Impact of alcohol on the histological and clinical progression of hepatitis C infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Effect of alcohol consumption on the progression of hepatitis C virus infection and risk of hepatocellular carcinoma in Japanese patients

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Drinking habits of subjects with hepatitis C virus-related chronic liver disease: prevalence and effect on clinical, virological and pathological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: results of a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

The alcoholic patient with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Reliability of assessment of alcohol intake based on personal interviews in a liver clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

The alcohol use disorder and associated disabilities interview schedule (AUDADIS): reliability of alcohol and drug modules in a clinical sample

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

The measure of life-time alcohol consumption in patients with cirrhosis: reproducibility and clinical relevance.

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Reliability of alcohol use indices. The Lifetime Drinking History and the MAST

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1542-3565%2805%2900407-6

7 January 2021

10.1016/S1542-3565(05)00407-6

Identifiers

DOI

1 reference

14 December 2017

1 reference

PubMed ID

16271348